Related Experiment Video
Updated: Jun 13, 2025
Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
Published on: September 6, 2024
Early biomarker for autism spectrum disorder unveiled - what are we learning?
Daniel A Rossignol1, Richard E Frye2,3
1Rossignol Medical Center, Aliso Viejo, CA, USA.
Insights
Early detection of Autism Spectrum Disorder (ASD) is vital. Identifying reliable biomarkers for maternal and environmental risk factors can revolutionize diagnosis and improve therapeutic strategies for children.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Autism Spectrum Disorder (ASD) affects 1 in 31 children in the U.S., necessitating early detection and intervention.
- Identifying reliable early biomarkers is crucial for revolutionizing ASD diagnosis and improving patient outcomes through timely therapeutic strategies.
Purpose of the Study:
- To review maternal, paternal, and environmental risk factors associated with ASD.
- To explore the role of biomarkers in identifying these contributing factors.
- To discuss future research directions and challenges in ASD biomarker discovery and application.
Main Methods:
- Literature review of studies on ASD risk factors.
- Analysis of existing research on biomarkers for ASD.
- Synthesis of expert opinions on future research and clinical translation.
Main Results:
- Key risk factors include immune dysregulation, metabolic conditions, toxicant exposures, and placental/amniotic factors.
- Biomarkers are essential tools for identifying these risk factors.
- Advances in multi-omics, imaging, epigenetics, and AI show promise for improving biomarker accuracy.
Conclusions:
- Future research focusing on maternal health and advanced biomarker technologies is critical for predicting ASD risk.
- Personalized interventions can be developed based on improved biomarker accuracy and earlier detection.
- Addressing challenges like biomarker reliability and ASD heterogeneity through validation studies and collaboration is key for clinical implementation.
Introduction:
Autism Spectrum Disorder (ASD) affects 1 in 31 children in the U.S. highlighting the urgent need for early detection and intervention. Identifying reliable early biomarkers could revolutionize ASD diagnosis and improve outcomes by enabling timely therapeutic strategies.
Areas Covered:
This review explores maternal, paternal, and environmental risk factors contributing to ASD, including immune dysregulation, metabolic conditions, toxicant exposures, and placental and amniotic factors. Biomarkers aid in identifying these factors.
Expert Opinion:
Future research in maternal health and biomarkers is crucial for predicting ASD risk and developing personalized interventions. Advances in multi-omics, imaging, epigenetics, and AI-driven analysis can improve biomarker accuracy, enabling earlier detection and targeted therapies. However, challenges such as biomarker reliability and ASD heterogeneity must be addressed through large-scale validation studies and interdisciplinary collaboration to translate these discoveries into clinical practice effectively.
